Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine vs conventional therapy in elderly AML
CTR20132284Phase 3Completed
- Sponsor
- Tigermed
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azacitidine in acute myeloid leukemia (AML), sponsored by Tigermed. Started May 2014; status: completed.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on CTR20132284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132284.